EX-99.1 2 talk-ex99_1.htm EX-99.1 EX-99.1

 

附录99.1

img227085625_0.jpg

Talkspace宣布2024年第三季度业绩

2024年第三季度总营业收入同比增长23%,增长幅度主要由45%推动

Payor营业收入的年度同比增长

净利润提高至190万美元。

由每股$440万的净亏损逐年增加

2024年第三季度调整后的EBITDA1 为240万美元

 

纽约,纽约 - 2024年10月29日Talkspace, Inc。 ("Talkspace"或"公司")(纳斯达克:TALK),今天公布了2024年第三季度财务业绩。

 

 

三个月

 

九个月

 

 

 

2024年9月30日 (未经查核)

 

结果

 

与前一年相比的变异%

 

结果

 

与前一年相比的变异%

(除非另有说明,数字单位为千)

 

 

 

 

 

 

 

 

期末合格受益人数 (以百万为单位)

 

158.1

 

40%

 

158.1

 

40%

完成付款会员次数

 

316.4

 

38%

 

899.2

 

50%

期末消费者活跃会员数

 

8.6

 

(35)%

 

8.6

 

(35)%

 

 

 

 

 

 

 

 

 

营业总收入

 

$47,399

 

23%

 

$138,873

 

29%

毛利润

 

$21,621

 

15%

 

$64,303

 

20%

归属于nCino, Inc.的净亏损

 

45.6%

 

 

 

46.3%

 

 

营业费用

 

$21,522

 

(10)%

 

$69,369

 

(6)%

净利润(损失)

 

$1,874

 

*

 

$(66)

 

100%

调整后的税前利润减除折旧及摊销后的费用 (1)

 

$2,350

 

*

 

$4,303

 

*

期末现金及现金等价物

 

$118,994

 

 

$118,994

 

* 百分比无意义。

(1)
调整后的EBITDA是一项非美国总部会计准则财务指标。有关该指标的定义和与最直接可比的美国总部会计准则相调解,请参见“非美国总部会计准则结果与美国总部会计准则结果的调解”。

 

Talkspace交出了稳固的第三季度财务业绩,营业收入增长23%,连续第三个获得调整后的EBITDA盈利的季度。我们在加强与重要付款伙伴的关系方面取得了重大进展,他们认为我们是最领先的全面、纯粹的行为健康提供者,真正认识到我们对临床卓越的差异化关注的重要性。

cohen博士表示:“心理健康危机仍然是一个关键问题,Talkspace通过我们高素质、有不同临床许可的供应商和创新平台,处于应对这种需求的最前沿。我特别为我们扩张至目前为止服务超过15800万被保险人一事感到自豪,其中包括为老年人、青少年和军工成员提供更多资源,这些人群具有独特且迫切的行为健康需求。我们创新的方法和战略性扩张使我们成为美国最大的行为远程健康网络,使我们能够满足对可及、高质量行为健康服务日益增长的需求。”

1


 

2024年第三季关键业绩指标

营业收入较去年同期增加23%,达到4740万美元,主要受到支付客户营收同比增长45%以及直接企业(“DTE”)营收同比增长17%的推动;部分抵销了消费营收同比下降30%。
毛利润比去年同期增加了15%,达到2160万美元,毛利率从上年同期的48.8%下降至45.6%,主要是由于营业收入组合向付款方转移。
营业费用为2150万美元,年减10%,主要因内部使用软体成本资本化,导致研发费用降低。
净利润为190万美元,较2023年第三季度440万美元的净亏损有所改善,主要是由于收入增加带动,部分抵销了成本增加。
调整后的息税折旧及摊提前结盈为240万美元,较2023年第三季度的(2.8)百万美元有所改善,主要原因是收入增加,部分抵销成本增加。

财务指导

Talkspace仍预计2024财政年度的营业收入在18500万到19500万的区间内,增长23-30%,且调整后的EBITDA在400万到800万的区间内。

 

2


 

会议看涨、演讲投影片和网路转播详情

2024年第三季度业绩发布会将于2024年10月29日星期二上午8:30举行。业绩发布会将透过投资者.talkspace.com提供听觉网路转播,美国参与者可拨打(888) 596-4144,国际参与者可拨打+1(646) 968-2525,并提供参与者代码2125813。通话完成后将立即提供重播,并持续约90天。

关于Talkspace

Talkspace(纳斯达克: TALK)是一家领先的虚拟行为健康照护提供者,致力于帮助人们通过获得高质量的心理照护来过上更健康、更快乐的生活。在Talkspace,我们相信心理照护对于整体健康至关重要,应该向每个人提供。

Talkspace开创了与注册治疗师能够进行文字交流的先河,现在提供全面的心理健康服务,包括个人、青少年和夫妻治疗,以及精神治疗和药物管理(18+)。通过Talkspace的核心治疗服务,会员可在几天内与数千名注册治疗师中的一名配对,进行现场视频、音频或聊天会话,以及无限制的非同步文字消息交流。

所有板块Talkspace提供的所有护理都是通过易于使用、完全加密的网络和移动平台进行交付,符合HIPAA、联邦和州政府的要求。超过15800万名美国人通过他们的医疗保险计划、员工援助计划、我们与领先医疗公司的合作伙伴关系,或者作为他们的雇主、学校或政府机构的免费福利获得了Talkspace的服务。

欲了解更多资讯,请浏览www.talkspace.com。

 

 

对于投资者:

ICR Westwicke

TalkspaceIR@westwicke.com

 

媒体:

约翰·金

斯克德克

(310) 997-5963

jkim@skdknick.com

 

 

3


 

前瞻性陈述

本新闻稿包含根据1995年修订版《私人证券诉讼改革法案》的某些前瞻性陈述。所有不涉及历史事实的陈述应被视为前瞻性,包括有关我们财务状况、预期的财务表现、实现盈利能力、业务策略和计划、市场机会和扩张,以及我们管理层对未来运营目标的陈述。这些前瞻性陈述通常通过“预计”、“相信”、“思量”、“继续”、“可能”、“估计”、“预期”、“预测”、“未来”、“打算”、“可能”、“机会”、“计划”、“可能”、“潜在”、“预测”、“计划”、“策略”、“努力”、“目标”、“将”或“将会”等词语或表达来识别。缺乏这些词语并不意味著陈述不是前瞻性。前瞻性陈述是预测、预测和基于当前期望和假设的其他未来事件陈述,因此受风险和不确定性的影响。许多重要因素可能导致实际未来事件与本新闻稿中的前瞻性陈述有很大不同,其中包括但不限于:(i)我们的业务和我们运营的市场快速演变;(ii)我们行业中的快速技术变革;(iii)我们确保客户合同续订的能力;(iv)我们维护和扩大我们的治疗师、精神科医生和其他提供者网络的能力;(v)企业赞助的医疗保健普及率下降或新技术的出现可能对我们的DTE业务产生不利影响;(vi)如果我们或我们的供应商的安全措断失败或被侵犯;(vii)医疗保健行业法律、法规或趋势的变化以及我们在受严格监管的医疗保健行业营运的能力;和(viii)以及其他因素、风险和不确定性,详见我们最近于2024年3月13日向证券交易委员会(“SEC”)提交的最新年度报告Form 10-k中标题为“风险因素”的描述、随后的季报Form 10-Q和我们不定期向SEC提交的其他文件。这些文件确定并解决了可能导致实际事件和结果与前瞻性陈述不符的其他重要风险和不确定性。前瞻性陈述仅于其发布之日起有效。读者应谨慎对待前瞻性陈述,我们不承担任何责任并无意更新或修订这些前瞻性陈述,除非根据适用法律有此要求。我们不保证实现我们的期望。

4


 

Talkspace, Inc.

Condensed Consolidated Income Statements

 

 

 

Three Months Ended
September 30,

 

 

 

Nine Months Ended
September 30,

 

 

 

 

2024

 

2023

 

% Change

 

2024

 

2023

 

% Change

(in thousands, except percentages, share and per share data)

 

Unaudited

 

Unaudited

 

 

 

Unaudited

 

Unaudited

 

 

Revenue:

 

 

 

 

 

 

 

 

 

 

 

 

   Payor revenue

 

$32,039

 

$22,112

 

44.9

 

$90,492

 

$55,462

 

63.2

   DTE revenue

 

9,370

 

8,002

 

17.1

 

28,911

 

24,717

 

17.0

   Consumer revenue

 

5,990

 

8,532

 

(29.8)

 

19,470

 

27,448

 

(29.1)

Total revenue

 

47,399

 

38,646

 

22.6

 

138,873

 

107,627

 

29.0

Cost of revenues

 

25,778

 

19,797

 

30.2

 

74,570

 

54,218

 

37.5

Gross profit

 

21,621

 

18,849

 

14.7

 

64,303

 

53,409

 

20.4

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

   Research and development

 

2,352

 

4,180

 

(43.7)

 

8,254

 

13,704

 

(39.8)

   Clinical operations, net

 

1,677

 

1,405

 

19.4

 

4,802

 

4,681

 

2.6

   Sales and marketing

 

12,337

 

13,184

 

(6.4)

 

38,615

 

39,698

 

(2.7)

   General and administrative

 

5,156

 

5,259

 

(2.0)

 

17,698

 

15,952

 

10.9

Total operating expenses

 

21,522

 

24,028

 

(10.4)

 

69,369

 

74,035

 

(6.3)

Income (loss) from operations

 

99

 

(5,179)

 

 *

 

(5,066)

 

(20,626)

 

75.4

Financial (income), net

 

(1,701)

 

(779)

 

118.4

 

(5,123)

 

(2,915)

 

75.7

Income (loss) before taxes on income

 

1,800

 

(4,400)

 

 *

 

57

 

(17,711)

 

 *

Taxes on income

 

(74)

 

14

 

 *

 

123

 

165

 

(25.5)

Net income (loss)

 

$1,874

 

$(4,414)

 

 *

 

$(66)

 

$(17,876)

 

99.6

Net income (loss) per share:

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$0.01

 

$(0.03)

 

 *

 

$(0.00)

 

$(0.11)

 

99.6

Diluted

 

$0.01

 

$(0.03)

 

 *

 

$(0.00)

 

$(0.11)

 

99.6

Weighted average shares used to compute net income (loss) per share:

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

168,426,349

 

166,570,673

 

 

 

168,805,882

 

164,215,802

 

 

Diluted

 

176,227,040

 

166,570,673

 

 

 

168,805,882

 

164,215,802

 

 

* Percentage not meaningful.

 

5


 

Talkspace, Inc.

Condensed Consolidated Balance Sheets

 

 

 

 

 

 

September 30, 2024

 

 

December 31, 2023

 

(in thousands)

 

Unaudited

 

 

 

 

ASSETS

 

 

 

 

 

 

CURRENT ASSETS:

 

 

 

 

 

 

Cash and cash equivalents

 

$

118,994

 

 

$

123,908

 

Accounts receivable, net

 

 

9,602

 

 

 

10,174

 

Other current assets

 

 

2,922

 

 

 

5,718

 

Total current assets

 

 

131,518

 

 

 

139,800

 

Other long-term assets

 

 

6,713

 

 

 

2,421

 

Total assets

 

$

138,231

 

 

$

142,221

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

 

CURRENT LIABILITIES:

 

 

 

 

 

 

Accounts payable

 

$

8,299

 

 

$

6,111

 

Deferred revenues

 

 

3,507

 

 

 

3,069

 

Accrued expenses and other current liabilities

 

 

7,247

 

 

 

12,468

 

Total current liabilities

 

 

19,053

 

 

 

21,648

 

Warrant liabilities

 

 

1,048

 

 

 

1,842

 

Other liabilities

 

 

542

 

 

 

85

 

Total liabilities

 

 

20,643

 

 

 

23,575

 

STOCKHOLDERS’ EQUITY:

 

 

 

 

 

 

Common stock

 

 

17

 

 

 

16

 

Additional paid-in capital

 

 

388,021

 

 

 

389,014

 

Accumulated deficit

 

 

(270,450

)

 

 

(270,384

)

Total stockholders’ equity

 

 

117,588

 

 

 

118,646

 

Total liabilities and stockholders’ equity

 

$

138,231

 

 

$

142,221

 

 

 

 

 

 

 

 

 

 

 

 

 

 

6


 

Talkspace, Inc.

Condensed Consolidated Statements of Cash Flows

 

 

 

Nine Months Ended
September 30,

 

 

 

2024

 

 

2023

 

(in thousands)

 

Unaudited

 

 

Unaudited

 

Cash flows from operating activities:

 

 

 

 

 

 

Net loss

 

$

(66

)

 

$

(17,876

)

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

 

 

 

Depreciation and amortization

 

 

652

 

 

 

913

 

Stock-based compensation

 

 

7,290

 

 

 

6,401

 

Remeasurement of warrant liabilities

 

 

(794

)

 

 

647

 

Decrease in accounts receivable

 

 

572

 

 

 

1,668

 

Decrease (increase) in other current assets

 

 

2,796

 

 

 

(41

)

Increase in accounts payable

 

 

2,188

 

 

 

51

 

Increase (decrease) in deferred revenues

 

 

438

 

 

 

(733

)

Decrease in accrued expenses and other current liabilities

 

 

(5,220

)

 

 

(5,785

)

Other

 

 

(233

)

 

 

(108

)

Net cash provided by (used in) operating activities

 

 

7,623

 

 

 

(14,863

)

Cash flows from investing activities:

 

 

 

 

 

 

Capitalized internal-use software costs

 

 

(3,768

)

 

 

 

Other

 

 

(69

)

 

 

(10

)

Net cash used in investing activities

 

 

(3,837

)

 

 

(10

)

Cash flows from financing activities:

 

 

 

 

 

 

Proceeds from exercise of stock options

 

 

1,616

 

 

 

2,059

 

Payments for employee taxes withheld related to vested stock-based awards

 

 

(2,312

)

 

 

(399

)

Repurchase and cancellation of common stock

 

 

(8,004

)

 

 

 

Net cash (used in) provided by financing activities

 

 

(8,700

)

 

 

1,660

 

Net decrease in cash and cash equivalents

 

 

(4,914

)

 

 

(13,213

)

Cash and cash equivalents at the beginning of the period

 

 

123,908

 

 

 

138,545

 

Cash and cash equivalents at the end of the period

 

$

118,994

 

 

$

125,332

 

 

7


 

Non-GAAP Financial Measures

In addition to our financial results determined in accordance with GAAP, we believe adjusted EBITDA, a non-GAAP measure, is useful in evaluating our operating performance, and our management uses it as a key performance measure to assess our operating performance. Because adjusted EBITDA facilitates internal comparisons of our historical operating performance on a more consistent basis, we use this measure for business planning purposes and in evaluating acquisition opportunities. We also use adjusted EBITDA to evaluate our ongoing operations and for internal planning and forecasting purposes. We believe that this non-GAAP financial measure, when taken together with the corresponding GAAP financial measures, provides meaningful supplemental information regarding our performance by excluding certain items that may not be indicative of our business, results of operations or outlook. We believe that the use of adjusted EBITDA is helpful to our investors as it is a metric used by management in assessing the health of our business and our operating performance. However, non-GAAP financial information is presented for supplemental informational purposes only, has limitations as an analytical tool and should not be considered in isolation or as a substitute for financial information presented in accordance with GAAP.

Some of the limitations of adjusted EBITDA include (i) adjusted EBITDA does not necessarily reflect capital commitments to be paid in the future and (ii) although depreciation and amortization are non-cash charges, the underlying assets may need to be replaced and adjusted EBITDA does not reflect these requirements. In evaluating adjusted EBITDA, you should be aware that in the future we will incur expenses similar to the adjustments described herein. Our presentation of adjusted EBITDA should not be construed as an inference that our future results will be unaffected by these expenses or any unusual or non-recurring items. Our adjusted EBITDA may not be comparable to similarly titled measures of other companies because they may not calculate adjusted EBITDA in the same manner as we calculate the measure, limiting its usefulness as a comparative measure. Adjusted EBITDA should not be considered as an alternative to income (loss) before income taxes, net income (loss), income (loss) per share, or any other performance measures derived in accordance with U.S. GAAP. When evaluating our performance, you should consider adjusted EBITDA alongside other financial performance measures, including our net income (loss) and other GAAP results.

A reconciliation is provided below for adjusted EBITDA to net income (loss), the most directly comparable financial measure stated in accordance with GAAP. Investors are encouraged to review our financial statements prepared in accordance with GAAP and the reconciliation of our non-GAAP financial measure to its most directly comparable GAAP financial measure, and not to rely on any single financial measure to evaluate our business. We do not provide a forward-looking reconciliation of adjusted EBITDA guidance as the amount and significance of the reconciling items required to develop meaningful comparable GAAP financial measures cannot be estimated at this time without unreasonable efforts. These reconciling items could be meaningful.

 

8


 

Adjusted EBITDA

We calculate adjusted EBITDA as net income (loss) adjusted to exclude (i) depreciation and amortization, (ii) interest and other expenses (income), net, (iii) tax benefit and expense, (iv) stock-based compensation expense, and (v) certain non-recurring expenses, where applicable.

 

Talkspace, Inc.

Reconciliation of Non-GAAP Results to GAAP Results

 

 

 

Three Months Ended
September 30,

 

 

Nine Months Ended
September 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

(in thousands)

 

Unaudited

 

 

Unaudited

 

 

Unaudited

 

 

Unaudited

 

Net income (loss)

 

$

1,874

 

 

$

(4,414

)

 

$

(66

)

 

$

(17,876

)

Add:

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

231

 

 

 

305

 

 

 

652

 

 

 

913

 

Financial (income), net (1)

 

 

(1,701

)

 

 

(779

)

 

 

(5,123

)

 

 

(2,915

)

Taxes on income

 

 

(74

)

 

 

14

 

 

 

123

 

 

 

165

 

Stock-based compensation

 

 

1,931

 

 

 

1,969

 

 

 

7,290

 

 

 

6,401

 

Non-recurring expenses (2)

 

 

89

 

 

 

105

 

 

 

1,427

 

 

 

89

 

Adjusted EBITDA

 

$

2,350

 

 

$

(2,800

)

 

$

4,303

 

 

$

(13,223

)

(1)
For the three months ended September 30, 2024, financial (income), net primarily consisted of $1.5 million of interest income from our money market accounts and $0.3 million in non-cash gains resulting from the remeasurement of warrant liabilities. For the nine months ended September 30, 2024, financial (income), net primarily consisted of $4.6 million of interest income from our money market accounts and $0.8 million in non-cash gains resulting from the remeasurement of warrant liabilities. For the three months ended September 30, 2023, financial (income), net primarily consisted of $1.6 million of interest income from our money market accounts, partially offset by $0.8 million in non-cash losses resulting from the remeasurement of warrant liabilities. For the nine months ended September 30, 2023, financial (income), net primarily consisted of $3.7 million of interest income from our money market accounts, partially offset by $0.6 million in non-cash losses resulting from the remeasurement of warrant liabilities.
(2)
For the nine months ended September 30, 2024, non-recurring expenses primarily consisted of severance costs related to the departure of key executives of the Company and other related costs. For the three and nine months ended September 30, 2023, non-recurring expenses primarily consisted in losses resulting from the disposition of fixed assets.

9